Results 221 to 230 of about 87,437 (368)

AML beyond the boundaries of daunomycin and cytarabine [PDF]

, 2003
Bob Löwenberg
openalex   +1 more source

Efficacy and Safety of the Third‐Generation Tyrosine Kinase Inhibitor Olverembatinib in Combination With Inotuzumab Ozogamicin for the Treatment of Adult Philadelphia Chromosome‐Positive Acute Lymphoblastic Leukemia Patients With Refractory/Relapsed Disease or Persistent Minimal Residual Disease Bridging to Hematopoietic Stem Cell Transplantation

American Journal of Hematology, Volume 100, Issue 10, Page 1924-1928, October 2025.
Xiaoyu Zhang, Yigeng Cao, Jialin Wei, Weihua Zhai, Qiaoling Ma, Chen Liang, Xin Chen, Wenbin Cao, Donglin Yang, Aiming Pang, Yi He, Sizhou Feng, Mingzhe Han, Rongli Zhang, Erlie Jiang   +14 more
wiley   +1 more source

Targeting the Ubiquitin–Proteasome System for Cancer

MedComm, Volume 6, Issue 10, October 2025.
This figure shows the mechanism of protein degradation by ubiquitin–proteasome system. The process begins with ubiquitin activation by the E1 enzyme, forming a thioester bond between E1's cysteine residue and ubiquitin's glycine carboxyl group, powered by ATP hydrolysis.
Zhaoyun Liu, Jiao Lai, Ziyu Ma, Jianhua Pan, Chun Yang, Rong Fu   +5 more
wiley   +1 more source

Deoxycytidine kinase and cN‐II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine [PDF]

, 2003
Carlos M. Galmarini, Xavier Thomas, Kathryn Graham, Assia El Jafaari, Emeline Cros, Lars Petter Jordheim, John R. Mackey, Charles Dumontet   +7 more
openalex   +1 more source

Prevalence and Clinical Significance of Potential Drug-Drug Interactions in Hospitalized Pediatric Oncology Patients: A Prospective Pharmacoepidemiologic Study. [PDF]

Cancers (Basel)
Zekavat OR, Zarsanj N, Sadeghdoust A, Lavu A, Bordbar M, Eltonsy S, Peymani P.   +6 more
europepmc   +1 more source

The past is the future: innovative designs in acute stroke therapy trials [PDF]

, 2005
Berry, D.A., Krams, M., Lees, K.R.
core   +1 more source

Chemotherapy for Acute Myelogenous Leukemia in the Elderly With Cytarabine, Mitoxantrone, and Granulocyte-Macrophage Colony-Stimulating Factor

, 2001
Matt Kalaycio, Brad Pohlman, Paul Elson, Alan Lichtin, Mohamad A. Hussein, Barb Tripp, and Steve Andresen   +6 more
openalex   +1 more source

Cytarabine-induced corneal toxicity [PDF]

, 2003
J Lochhead, John F. Salmon, A J Bron
openalex   +1 more source

Calumenin, A Calcium‐Binding Modulatory Protein, Effective in Pathological Calcifications and Cancers, With Therapeutic Application Promise

FASEB BioAdvances, Volume 7, Issue 10, October 2025.
Calumenin (CALU) is effective in calcium homeostasis, involved in various cellular processes, ER‐related functions, normal calcification processes, pathological calcium deposits, inflammatory diseases, and cancers. Additionally, it has been linked to cancer by controlling the γ‐carboxylation of vitamin K‐dependent proteins linked to cancer.
Parinaz Nasri Nasrabadi, Babak Jahangiri, Zahra Amiri, Forouzandeh Mahjoubi, Fatemeh Masoumi, Alireza Zomorodipour   +5 more
wiley   +1 more source

Feline leukaemia virus (FeLV) infection in domestic pet cats in Australia and New Zealand: Guidelines for diagnosis, prevention and management

Australian Veterinary Journal, Volume 103, Issue 10, Page 617-635, October 2025.
Progressive feline leukaemia virus (FeLV) infection dramatically shortens the lives of infected cats, causing acquired immunodeficiency, aplastic anaemia, lymphoma, leukaemia and other myeloproliferative diseases. The potential impact of regressive FeLV infection on the development of disease remains largely unknown, although there is evidence it ...
ME Westman, SJ Coggins, M van Dorsselaer, JM Norris, RA Squires, M Thompson, R Malik   +6 more
wiley   +1 more source